All news

Goldman Sachs reveals 2.87% Qiagen stake

Alpha Vantage · The Globe and Mail · · AI-summarised by FinFlash

Goldman Sachs reported a 2.87% stake in Qiagen via ordinary shares and derivatives, including call options, warrants, swaps, and convertible bonds. The position is held across multiple Goldman Sachs entities. Analysts rate Qiagen (QGEN) a Hold with a $36 price target. The filing increases transparency into Qiagen's shareholder structure amid heightened institutional activity.

Read original source

GS company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.